Introduction
O rganized breast cancer screening requires high attendance rates to be an effective and efficient public health intervention. In Europe, attendance rates of >75% are recommended. 1 It is therefore important to investigate interventions encouraging women to make an informed choice to attend screening.
Breast Cancer Awareness Month (BCAM) is a worldwide event held every October to increase awareness and raise funds for research. In the USA, where opportunistic screening is prevalent, October is the most likely month for women to attend screening; however, the impact of BCAM on attendance and diagnosis appears to have decreased over time. 2, 3 In Norway, the Breast Cancer Society and Cancer Society have organized BCAM events since 1999.
The Norwegian Breast Cancer Screening Programme offers population-based, biennial screening to women aged 50-69. The programme began in 1996 and became nationwide in 2005; the target group consists of roughly 600 000 women per screening round and attendance is $75%. 4 Invitations to screening are sent regularly throughout the year and dispatched 2-4 weeks ahead of a pre-scheduled appointment. Reminders are sent to non-attenders to schedule a new appointment. This reminder increases overall attendance by five percentage points. 4 Self-referral rarely occurs and is usually related to moving or breast cancer symptoms. A survey of mammography use in Norway in 2005 and 2008 demonstrated that, of all mammography examinations among women aged 50-69, roughly 5-6% were conducted at private institutions. 5 It is unknown, however, what proportion of these examinations were for screening and no information is available about opportunistic screening from after this time.
Despite increased focus on breast cancer awareness in October, to the best of our knowledge, seasonal trends in organized breast cancer screening attendance in Europe have not been investigated. The main purpose of this study was to describe monthly attendance at the Norwegian Breast Cancer Screening Programme.
Methods
This study was permitted under the Cancer Registry Regulations (Kreftregisterforskriften). 6 Information from 2005 to 2015 about screening appointment date, attendance, age, year of screening, self-referral status, whether women were invited to a mobile or stationary unit, whether women had a scheduled appointment during their birthday month, and screening area was extracted from the Cancer Registry of Norway databases. The exposure of interest was month of scheduled appointment. This was determined using screening date for attenders and the last scheduled appointment during a screening round for non-attenders. The outcome of interest was attendance following an invitation or reminder.
Descriptive analyses including frequencies and proportions were performed and tabulated. Generalized estimating equations with a logit link and robust variance-covariance matrix were used to estimate the crude and adjusted odds of monthly screening attendance with 95% CI. 7 Additional covariates in the adjusted model were: age, year of screening, self-referral status, whether women were invited to a mobile unit, whether women had a scheduled appointment during their birthday month, and screening area.
Results
Information about 2 912 117 screening invitations sent to 789 171 women associated with 2 188 471 screening examinations were included in our analyses (median number of invitations per woman 3, interquartile range 1-4). Mean age at invitation was 59 years (SD 5.7 years).
Overall attendance was 75.2% (range 62.3-82.2%) across the 16 screening areas nationwide. Attendance was lowest in August (73.1%) and highest in June (76.5%; Table 1 ). The programme does not offer regular screening services during July: only women who reschedule their original appointment are screened. Women with an appointment in July (n = 60) were excluded from regression analyses with appointment month as a covariate because attendance was 100%.
The adjusted odds of attendance were 0.93-0.98 times lower in January, February, March, August, September or December compared with October (P 0.003 for all). Relative to October, the adjusted odds of attendance were not significantly different in April or November (P > 0.29 for both), but were 1.02-1.07 times higher in May and June (P < 0.001 for both).
Self-referral showed the strongest effect on screening attendance, OR adj = 4.88 (95% CI: 4.50, 5.29). Moreover, the adjusted odds of attendance were 1.45 times greater (95% CI: 1.43, 1.47) for women invited to mobile compared with stationary units. Screening scheduled during one's birthday month was not significantly associated with attendance (P = 0.060).
Discussion
The odds of attending the screening programme in a given month relative to October fluctuated by AE7% during 2005-15, and only in May and June were the odds of attendance significantly higher than October. Overall, however, these results failed to demonstrate a strong association between BCAM and screening attendance in October. BCAM may have contributed to a marginal increase in monthly attendance in the screening programme during October and possibly November, but seasonal variation in weather and holidays may also explain observed variations in monthly attendance and were not directly addressed in this study.
Self-referral had a substantially larger effect on screening attendance than appointment month. This was expected since these women are a self-selected group with a special interest in screening. However, invitation letters sent by the Cancer Registry state a place and time for examination and could therefore reduce the likelihood that women self-refer to screening as a reaction to BCAM. In fact, only 9806 women (0.3%) self-referred to screening during the study period. A possible interpretation of this is that the invitation system in Norway reduces monthly variation in attendance compared with countries where women schedule their own appointments. Combined with a relatively high baseline attendance rate, this may make attendance at routine screening in Norway robust to 'awareness shocks'. 8 The goals of BCAM might thus be reached independently of screening attendance in October. In fact, BCAM could be an important factor in maintaining the high level of screening attendance in Norway.
Determining the yearly effect of BCAM on attendance was outside the scope of our study and some variation over time is expected. However, overall attendance at the screening programme has been relatively stable since 2005 and a sensitivity analysis including an interaction effect between month and year in the adjusted regression model indicated this effect was negligible (all OR adj 0.99 or 1.00).
In Norway, there has been increased adoption of mobile screening in rural areas compared with urban areas. The increased adjusted odds of attendance at mobile units could therefore be related to enhanced access to screening due to shortening the travel distance to screening. Although our results were adjusted for screening area, this result should be interpreted with caution.
A small increase in colorectal screening attendance within a randomized controlled trial was observed for Norwegians aged 50-64 invited to screening around participant's birthdays [OR adj (95% CI): 1.15 (1.03, 1.28), P = 0.01]. 9 However, these findings were not replicated in our study, and preventive services letters sent around women's birthdays in the USA have been shown to be less effective than mammogram-specific reminders. 10 Interventions for increasing attendance to screening may therefore not be generalizable across different target populations.
In conclusion, the results of this study do not support the hypothesis that BCAM had a large effect on monthly attendance in the Norwegian screening programme during 2005-15. Other factors should be identified and studied further to increase adherence to screening.
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